{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T17:55:27Z","timestamp":1747158927745,"version":"3.40.5"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Finnish Registry for Kidney Diseases"}],"content-domain":{"domain":["diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.diabres.2013.12.010","type":"journal-article","created":{"date-parts":[[2013,12,25]],"date-time":"2013-12-25T15:45:12Z","timestamp":1387986312000},"page":"510-515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Medication among patients with type 1 diabetes and predialytic renal disease"],"prefix":"10.1016","volume":"103","author":[{"given":"Jaakko","family":"Helve","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6268-8117","authenticated-orcid":false,"given":"Reijo","family":"Sund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikko","family":"Haapio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4055-6954","authenticated-orcid":false,"given":"Per-Henrik","family":"Groop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carola","family":"Gr\u00f6nhagen-Riska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrik","family":"Finne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2013.12.010_bib0005","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.2337\/db08-1543","article-title":"The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes","volume":"58","author":"Groop","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2013.12.010_bib0010","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.2337\/dc10-0030","article-title":"Survival of patients with type 1 diabetes receiving renal replacement therapy in 1980\u20132007","volume":"33","author":"Haapio","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2013.12.010_bib0015","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s00125-011-2140-6","article-title":"Comorbidities and survival of patients with type 1 diabetes on renal replacement therapy","volume":"54","author":"Helve","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2013.12.010_bib0020","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1046\/j.1523-1755.2002.00636.x","article-title":"United States renal data system. Blood pressure and long-term mortality in United States hemodialysis patients: USRDS waves 3 and 4 study","volume":"62","author":"Foley","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.diabres.2013.12.010_bib0025","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1523-1755.2004.00473.x","article-title":"Cardiac medications and their association with cardiovascular events in incident dialysis patients: cause or effect","volume":"65","author":"Ishani","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.diabres.2013.12.010_bib0030","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1046\/j.1523-1755.2002.00355.x","article-title":"Calcium channel blocker use and mortality among patients with end-stage renal disease","volume":"61","author":"Kestenbaum","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.diabres.2013.12.010_bib0035","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III)","volume":"285","author":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.diabres.2013.12.010_bib0040","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","author":"Heart Protection Study Collaborative Group","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2013.12.010_bib0045","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0140-6736(99)12323-7","article-title":"Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy","volume":"355","author":"Heart Outcomes Prevention Evaluation Study Investigators","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2013.12.010_bib0050","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The collaborative study group","volume":"329","author":"Lewis","year":"1993","journal-title":"N Engl J Med"},{"year":"2009","series-title":"FinDM II. On the register-based measurement of the prevalence and incidence of diabetes and its long-term complications. A technical report","author":"Sund","key":"10.1016\/j.diabres.2013.12.010_bib0055"},{"key":"10.1016\/j.diabres.2013.12.010_bib0060","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1093\/ndt\/gfp212","article-title":"Prescription of antihypertensive agents to haemodialysis patients: time trends and associations with patient characteristics, country and survival in the DOPPS","volume":"24","author":"Lopes","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.diabres.2013.12.010_bib0065","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1053\/j.ajkd.2003.08.028","article-title":"Characteristics of treated hypertension in incident hemodialysis and peritoneal dialysis patients","volume":"42","author":"Griffith","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.diabres.2013.12.010_bib0070","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (study of heart and renal protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2013.12.010_bib0075","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2013.12.010_bib0080","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","article-title":"Rosuvastatin and cardiovascular events in patients undergoing hemodialysis","volume":"360","author":"Fellstrom","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2013.12.010_bib0085","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2013.12.010_bib0090","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin\u2013receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2013.12.010_bib0095","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1056\/NEJMoa0907845","article-title":"A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease","volume":"361","author":"Pfeffer","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2013.12.010_bib0100","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJM199808273390903","article-title":"The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin","volume":"339","author":"Besarab","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2013.12.010_bib0105","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.jacc.2010.03.105","article-title":"Effects of telmisartan added to angiotensin-converting enzyme inhibitors on mortality and morbidity in hemodialysis patients with chronic heart failure: a double-blind, placebo-controlled trial","volume":"56","author":"Cice","year":"2010","journal-title":"JACC"},{"key":"10.1016\/j.diabres.2013.12.010_bib0110","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/S0735-1097(03)00241-9","article-title":"Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial","volume":"41","author":"Cice","year":"2003","journal-title":"JACC"},{"issue":"Suppl. 2","key":"10.1016\/j.diabres.2013.12.010_bib0115","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0272-6386(04)01107-2","article-title":"Dialysis outcomes and practice patterns study (DOPPS) data on medications in hemodialysis patients","volume":"44","author":"Andreucci","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.diabres.2013.12.010_bib0120","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/sj.ki.5002451","article-title":"Vitamin D levels and early mortality among incident hemodialysis patients","volume":"72","author":"Wolf","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.diabres.2013.12.010_bib0125","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1681\/ASN.2004070573","article-title":"Activated injectable vitamin D and hemodialysis survival: a historical cohort study","volume":"16","author":"Teng","year":"2005","journal-title":"J Am Soc Nephrol"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822713004439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822713004439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,7]],"date-time":"2018-10-07T16:55:39Z","timestamp":1538931339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822713004439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0168822713004439"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2013.12.010","relation":{},"ISSN":["0168-8227"],"issn-type":[{"type":"print","value":"0168-8227"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medication among patients with type 1 diabetes and predialytic renal disease","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2013.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}